Clinical Trials Logo

Cervical Precancerous Lesions clinical trials

View clinical trials related to Cervical Precancerous Lesions.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT00923702 Active, not recruiting - Cervical Cancer Clinical Trials

Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India

Start date: September 2009
Phase: Phase 4
Study type: Interventional

The primary study hypothesis wasthat a two-dose human papillomavirus (HPV) vaccine regimen would offer similar immunogenicity and protection as that of a three-dose regimen to girls against persistent HPV infection and cervical neoplasia caused by HPV types included in the vaccine. The Government of India stopped vaccination in all the HPV vaccine trials in the country in April 2010 due to reasons not related to this study.